My apologies, I didn't realize the Wall Street Journal was referencing IMGG when they wrote that article. Oh wait, they weren't, that was you. It's an observation I am making and sharing. Just like you were sharing. I don't believe there is anything in there pertaining to IMGG, rather info relating to other companies who may have been skating by on approvals due to their use of an "independant" third party. Likely some company with an in at the FDA. That is something we obviously don't have and I believe it is misleading to post that article here as if it has something to do with IMGG. In my opinion it does not.
SHAKA
News 
Market Data 
Discover 
AI
